4//SEC Filing
ANTARES PHARMA, INC. 4
Accession 0001181431-13-032916
CIK 0001016169operating
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:40 PM ET
Size
8.5 KB
Accession
0001181431-13-032916
Insider Transaction Report
Form 4
DAVE KAUSHIK J
Executive Vice President
Transactions
- Sale
Common Stock
2013-06-03$4.01/sh−48,000$192,547→ 265,028 total - Exercise/Conversion
Stock Option (right to buy)
2013-06-03−48,000→ 647,195 totalExercise: $0.47Exp: 2018-11-12→ Common Stock (48,000 underlying) - Exercise/Conversion
Common Stock
2013-06-03$0.47/sh+48,000$22,560→ 313,028 total
Footnotes (2)
- [F1]The stock option exercises and sales of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The options vested in equal quarterly installments over three years following the grant date.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001016169
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:40 PM ET
- Size
- 8.5 KB